Fig. 6From: Predicting response to neo-adjuvant chemotherapy and assessment of residual disease in breast cancer using contrast-enhanced spectral mammography: a combined qualitative and quantitative approacha Pre-NAC mammogram; spiculated LOQ mass. b Post-NAC mammogram; marked reduction in size. c Pre-NAC CESM; separated lesions. d Post-NAC CESM CC view showing no residual enhancing lesions. CESM classified this patient as a complete responder. Pathology; Miller-Payne grade 5Back to article page